Social media (SoMe) are platforms that enable users to create and share content, or participate in social networking. Medical education is rapidly moving into a post-COVID world, with the use of SoMe becoming ever more prominent. We explore the risks and benefits of using this technology to assist learning and examine these in light of relevant educational theory.Benefits include accessibility to experts, opportunities for mentorship, access to support networks, resource sharing and global participation. Following the 'Black Lives Matter' movement, SoMe has provided the impetus to adapt medical curricula to address health inequities in minority ethnic individuals.Key criticisms focus on superficial learning, psychological safety, correctly identifying level of expertise, professionalism and ownership protections for content creators. Users have limited ways to manage risk.The medical education community must adapt and rapidly critique SoMe innovations so that they can be better developed and learned from, all the while remaining vigilant.
The COVID‐19 pandemic has left dermatology practice in disarray globally. Patient‐facing services have been compromised for patients and clinicians alike. The implications of such disruption for dermatology undergraduate education are unknown. Numerous undergraduate programmes have faced disruption, with teaching postponed or featuring reformatted, ad‐hoc delivery. Following the pandemic, it is anticipated UK medical education will face a ‘new normal’, with a much greater emphasis on technology‐enhanced learning
1
. This presents a challenge to dermatology educators as we reflect upon our undergraduate curriculum delivery in an uncertain climate.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.